External Funding Opportunities

Funding Opportunity

Deadline

NIH Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborations with the NCI-supported Drug Resistance and Sensitivity Network (DRSN)

April 4

NIH Multidisciplinary Studies of HIV/AIDS and Aging  This FOA encourages applications at the intersection of HIV and aging by addressing two overarching objectives: 1) to improve understanding of biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment; and 2) to improve approaches for testing, prevention, and treatment of HIV infection, and management of HIV-related comorbidities, co-infections, and complications in different populations and cultural settings by applying our current understanding of aging science.

  • R01 Deadline: May 7
  • R21 Deadline: May 7

 May 7

NIH Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01) 

June 2

NIH Notice of Special Interest (NOSI): Leveraging Real-World Imaging Data for Artificial Intelligence-based Modeling and Early Detection of Abdominal Cancers 

June 5

NIH-NCI Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21)

June 8

NIH-NCI Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01)

June 8

NIH-NCI Sustained Support for Informatics Technologies for Cancer Research and Management (U24)

June 8

NIH-NCI Advanced Development of Informatics Technologies for Cancer Research and Management (U24)

June 8

NIH-NCI The NCI Transition Career Development Award (K22)

June 12

NIH Tobacco Regulatory Science (R01)

July 14

NIH-NCI Modular R01s in Cancer Control and Population Sciences (R01)

November 8

NIH Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards  The overarching goal of this pilot program is to enhance the retention of investigators facing critical life events who are transitioning to the first renewal of their first independent research project grant award or to a second new NIH research project grant award. Retention at the first renewal or continuous NIH research project grant support is crucial for sustaining both the ongoing research NIH has made an investment in and for retaining diversity in the biomedical research workforce. Deadline:  Varies by awarding IC

 Varies

NIH Notice of Special Interest (NOSI): Use of Biological "High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers  The purpose of this Notice of Special Interest (NOSI) is to continue advancing our understanding of the risks, development, progression, diagnosis, and treatment of malignancies observed in individuals with an underlying human immunodeficiency virus (HIV) infection or acquired immunodeficiency syndrome (AIDS), particularly the non-AIDS defining malignancies which are now a leading cause of death in HIV-infected individuals. Research efforts that identify specific contributions of HIV infection and its potential interaction with other pathogens towards the development and pathogenesis of these cancers and provide information on the clinical outcomes of such cancers in the HIV-infected population are sought.  Deadline:  Applies to due dates on or after May 7, 2020 through January 8, 2023

 Varies

NIH Notice of Special Interest (NOSI): Synthetic Biology for Biomedical Applications  The purpose of this NOSI is to encouraging new applications to advance research activities relevant to synthetic biology.  The overarching goal(s) of this Notice are to: 1) develop tools and technologies to control and reprogram biological systems; 2) apply synthetic biology approaches for the development of biomedical technologies; 3) increase the fundamental understanding of synthetic biology concepts as they relate to human health; and 4) gain fundamental biological knowledge through the application of synthetic biology approaches. Deadline: Varies by IC

 Varies

NIH Research Supplements to Promote Diversity in Health-Related Research  The NIH and the CDC hereby notify PD(s)/PI(s) holding specific types of research grants  that funds are available for administrative supplements to enhance the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from diverse backgrounds, including those from groups that have been shown to be underrepresented in health-related research. This supplement opportunity is also available to PD(s)/PI(s) of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project.  Administrative supplements must support work within the scope of the original project. Deadline: Varies by awarding IC

 Varies

NIH Notice of Special Interest (NOSI): Understanding the effects of cancer and cancer treatment on aging trajectories and aging outcomes  The purpose of this NOSI is to solicit investigator-initiated applications that aim to better understand the effects of a cancer diagnosis and subsequent cancer treatment on aging trajectories and aging outcomes. Applications for this initiative should submit through funding opportunity announcements (FOAs) or any reissues of these announcements as noted in this notice.

Varies

Funding Opportunity

Deadline

Kidney Cancer Association opportunities The Kidney Cancer Association is pleased to begin accepting applications for its 4 Young Investigator Awards (YIAs), 2 Advanced Discovery Awards (ADAs), and (New!) Psychosocial Focus Award. LOI Applications open March 1, 2021 and will close April 29, 2021. April 29

DoD-CDMRP Breast Cancer Research Program  The BCRP challenges the scientific community to design research that will address the urgency of ending breast cancer. Specifically, the BCRP seeks to accelerate high-impact research with clinical relevance, encourage innovation and stimulate creativity, and facilitate productive collaborations. The following FY21 opportunities have been announced:

  • Breakthrough Award Levels 1 and 2  Letter of Intent due March 11; Application due March 25
  • Breakthrough Award Level 3  Preproposal due March 12; Invited application due June 23
  • Breakthrough Award Level 4  Preproposal due March 12; Invited application due June 23
  • Era of Hope Scholar Award  Letter of Intent due March 11; Application due March 25
  • Innovator Award  Preproposal due March 12; Application due June 23
  • Transformative Breast Cancer Consortium Award  Preproposal due March 12; Invited application due June 23
Varies

NSF Division of Molecular and Cellular Biosciences: Investigator-initiated research projects (MCB)  

On-going

DOE-JGI CSP New Investigator 

On-going

NSF Big Ideas updates

Varies

DOD-CDMRP FY21 Lung Cancer Research Program (LCRP)  The goal of the FY21 LCRP is to eradicate deaths and suffering from lung cancer to better the health and welfare of military Service members, Veterans, and the American public. As such, the LCRP will support and integrate research from multiple disciplines for risk assessment, prevention, early detection, diagnosis, and treatment for the control and cure of lung cancer. Mechanisms include: Career Development Award and Concept Award. Deadlines: April 6 – Pre-application; April 20 - Application

Varies

DOD-CDMRP Ovarian Cancer Research Program (OCRP)  The mission of the OCRP is to support patient-centered research to prevent, detect, treat, and cure ovarian cancer to enhance the health and well-being of Service members, Veterans, their family members, and all women impacted by this disease. Mechanisms include: Clinical Translational Research Award, Investigator-Initiated Research Award, Academy Award, Pilot Award and Proteogenomics Research Award. Deadlines: April 1 – Pre-application; July 8 – Application

Varies

Damon Runyon Cancer Research Foundation  The Damon Runyon Cancer Research Foundation, we fund high-risk, high-reward cancer research.  The foundation provides a variety of cancer-related funding opportunities. Deadline:  Varies by opportunity

Varies